Clinical and Molecular Evaluation of HER2-Low and HER2-Ultralow Breast Cancer in the Penelope-B Clinical Trial Cohort
Modern Pathology · 2026-06 · 39 (6) · 101006
DOI: 10.1016/j.modpat.2026.101006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Modern Pathology, 2026-06. Verfasst von Carsten Denkert und 36 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pathology, Philipps-University Marburg and University Hospital Marburg, University Cancer Center Frankfurt-Marburg, Marburg, Germany. El…. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Breast Neoplasms, Erb-b2 Receptor Tyrosine Kinases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bundesministerium für Forschung, Technologie und Raumfahrt.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Pathology, Philipps-University Marburg and University Hospital Marburg, University Cancer Center Frankfurt-Marburg, Marburg, Germany. Electronic address: carsten.denkert@uni-marburg.de.
- German Breast Group c/o German Breast Group Forschungs GmbH, Neu-Isenburg, Germany.
- Institute of Pathology, Philipps-University Marburg and University Hospital Marburg, University Cancer Center Frankfurt-Marburg, Marburg, Germany.
- Medical Faculty Mannheim, Department of Gynecology, Heidelberg University, University Hospital Mannheim, Germany.
- Department of Medical Oncology, Instituto de Investigación Sanitaria Gregorio Marañon, Centro de Investigación Biomédica en Red de Cáncer, Universidad Complutense, Madrid, Spain; Spanish Breast Cancer Group, Grupo Españ…
- Department of Gynecology and Obstetrics, Goethe-University Frankfurt, University Cancer Center Frankfurt-Marburg, Frankfurt, Germany.
Förderung
- Bundesministerium für Forschung, Technologie und Raumfahrt
Zitieren
APA
Denkert, C., Rachakonda, S., Pehl, A., Marmé, F., Martin, M., Karn, T., Untch, M., Bonnefoi, H., Kim, S. B., Hirmas, N., Bear, H., Witkiewicz, A. K., Im, S. A., DeMichele, A., Van't Veer, L., McCarthy, N., Stiewe, T., Jank, P., Gelmon, K. A., …, & Loibl, S. (2026). Clinical and Molecular Evaluation of HER2-Low and HER2-Ultralow Breast Cancer in the Penelope-B Clinical Trial Cohort. Modern Pathology, 39(6), 101006. https://doi.org/10.1016/j.modpat.2026.101006
Vancouver
Denkert C, Rachakonda S, Pehl A, Marmé F, Martin M, Karn T, et al. Clinical and Molecular Evaluation of HER2-Low and HER2-Ultralow Breast Cancer in the Penelope-B Clinical Trial Cohort. Modern Pathology. 2026;39(6):101006. doi:10.1016/j.modpat.2026.101006
BibTeX
@article{Denkert2026,
author = {Denkert, Carsten and Rachakonda, Sivaramakrishna and Pehl, Anika and Marmé, Frederik and Martin, Miguel and Karn, Thomas and Untch, Michael and Bonnefoi, Hervé and Kim, Sung-Bae and Hirmas, Nader and Bear, Harry and Witkiewicz, Agnieszka K and Im, Seock-Ah and DeMichele, Angela and Van't Veer, Laura and McCarthy, Nicole and Stiewe, Thorsten and Jank, Paul and Gelmon, Karen A and García-Sáenz, José A and Westhoff, Christina and Kelly, Catherine M and Reimer, Toralf and Olivé, Mireia M and Knudsen, Erik S and van Mackelenbergh, Marion and Rojo, Federico and Frickel, Nadine and Fasching, Peter A and Teply-Szymanski, Julia and Toi, Masakazu and Rugo, Hope S and Gnant, Michael and Makris, Andreas and Felder, Bärbel and Nekljudova, Valentina and Loibl, Sibylle},
title = {Clinical and Molecular Evaluation of HER2-Low and HER2-Ultralow Breast Cancer in the Penelope-B Clinical Trial Cohort},
journal = {Modern Pathology},
year = {2026},
volume = {39},
number = {6},
pages = {101006},
doi = {10.1016/j.modpat.2026.101006}
}
EUVIMED